Preventive use of hepatoprotectors yields limited efficacy on the liver toxicity of anti-tuberculosis agents in a large cohort of Chinese patients

Author:

Wu Shanshan1,Xia Yinyin2,Lv Xiaozhen1,Tang Shaowen1,Yang Zhirong1,Zhang Yuan1,Wang Xiaomeng3,Hu Daiyu4,Liu Feiying5,Yuan Yanli6,Tu Dehua7,Sun Feng1,Zhou Lin2,Zhan Siyan1

Affiliation:

1. Department of Epidemiology and Biostatistics; School of Public Health; Peking University; Beijing China

2. Center for Tuberculosis Control and Prevention; Chinese Center for Disease Control and Prevention; Beijing China

3. Center for Disease Control and Prevention in Zhejiang Province; Hangzhou China

4. Center for Disease Control and Prevention in Chongqing Municipality; Chongqing China

5. Center for Disease Control and Prevention in Guangxi Zhuang Autonomous Region; Nanning China

6. Center for Disease Control and Prevention in Jilin Province; Changchun China

7. Beijing Institute for Tuberculosis Control; Beijing China

Funder

China Program for the Global Fund to Fight TB

National Natural Science Foundation of China

Beijing Natural Science Foundation

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Reference23 articles.

1. Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis;Yee;Am. J. Respir. Crit. Care Med.,2003

2. An assessment of factors contributing to treatment adherence and knowledge of TB transmission among patients on TB treatment;Kaona;BMC Public Health,2004

3. Non-adherence to tuberculosis treatment in the eastern Tarai of Nepal;Wares;Int. J. Tuberc. Lung Dis.,2003

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3